Viewing Study NCT04224649



Ignite Creation Date: 2024-05-06 @ 2:08 PM
Last Modification Date: 2024-10-26 @ 1:25 PM
Study NCT ID: NCT04224649
Status: UNKNOWN
Last Update Posted: 2020-01-13
First Post: 2019-09-05

Brief Title: To Evaluate the Efficacy and Safety of Injection With HARA as Compared to Restylane Lidocaine in Temporary Correction of Nasolabial Folds
Sponsor: Huons Co Ltd
Organization: Huons Co Ltd

Study Overview

Official Title: A Single Center Randomized Subject Evaluator-blind Matched Pairs Active-controlled Design Pivotal Study to Evaluate the Efficacy and Safety of Injection With HARA as Compared to Restylane Lidocaine in Temporary Correction of Nasolabial Folds
Status: UNKNOWN
Status Verified Date: 2020-01
Last Known Status: RECRUITING
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: Investigational Device HARA Hyaluronic Acid Filler
Title A Single center Randomized Subject Evaluator-blind Matched pairs Active-controlled design Pivotal study to Evaluate the Efficacy and Safety of Injection with HARA as Compared to Restylane Lidocaine in temporary Correction of Nasolabial folds
Sites and investigators Chung-ang University HospitalSeoul Beom-Joon Kim MD PhD
Objective To compare the non-inferiority of HARA with Restylane Lidocaine for evaluation of the efficacy and safety on Nasolabial Folds
Detailed Description: None

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: False
Is a FDA Regulated Device?: False
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None